|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/50 | |
| A61K 31/554 | |||
| A61K 31/785 | |||
| A61P 3/06 | |||
| A61P 1/12 | |||
| A61K 9/16 | |||
| A61P 1/04 | |||
| A61P 1/18 | |||
| A61P 43/00 |
| (11) | Number of the document | 3413877 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17705974.8 |
| Date of filing the European patent application | 2017-02-09 | |
| (97) | Date of publication of the European application | 2018-12-19 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SE2017/050127 |
| Date | 2017-02-09 |
| (87) | Number | WO 2017/138877 |
| Date | 2017-08-17 |
| (30) | Number | Date | Country code |
| 1650156 | 2016-02-09 | SE |
| (72) |
GILLBERG, Per-Göran, SE
GUSTAFSSON, Nils Ove, SE
LINDBERG, Nils-Olof, SE
ELVERSSON, Jessica, SE
|
| (73) |
Albireo AB,
Arvid Wallgrens Backe 20, 413 46 Göteborg,
SE
|
| (54) | ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF |
| ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF |